Jade Biosciences, Inc.
JBIO
$15.26
$0.040.26%
NASDAQ
| 03/31/2026 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 523.48% | -- | |||
| Total Receivables | -- | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | 831.87% | -- | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | -- | -- | |||
| Total Current Assets | 528.19% | -- | |||
|
|
|||||
| Total Current Assets | 528.19% | -- | |||
| Net Property, Plant & Equipment | 10.72% | -- | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | -98.58% | -- | |||
| Total Assets | 467.13% | -- | |||
|
|
|||||
| Total Accounts Payable | -9.63% | -- | |||
| Total Accrued Expenses | 59.78% | -- | |||
| Short-term Debt | -- | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | -- | -- | |||
| Total Finance Division Other Current Liabilities | 30.61% | -- | |||
| Total Other Current Liabilities | 30.61% | -- | |||
| Total Current Liabilities | 38.90% | -- | |||
|
|
|||||
| Total Current Liabilities | 38.90% | -- | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | -- | -- | |||
| Capital Leases | -13.28% | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | -- | -- | |||
| Total Liabilities | -83.57% | -- | |||
|
|
|||||
| Common Stock & APIC | 31,130.71% | -- | |||
| Retained Earnings | -152.22% | -- | |||
| Treasury Stock & Other | -- | -- | |||
| Total Common Equity | 455.00% | -- | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | 0.00% | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | 0.00% | -- | |||
|
|
|||||
| Total Common Equity | 455.00% | -- | |||
| Total Preferred Equity | 0.00% | -- | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | 455.01% | -- | |||
|
|
|||||